GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » EBIT per Share

Chordia Therapeutics (TSE:190A) EBIT per Share : 円-30.67 (TTM As of Aug. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics EBIT per Share?

Chordia Therapeutics's EBIT per Share for the six months ended in Aug. 2024 was 円-30.67. Its EBIT per Share for the trailing twelve months (TTM) ended in Aug. 2024 was 円-30.67.

During the past 12 months, the average EBIT per Share Growth Rate of Chordia Therapeutics was -916.40% per year. During the past 3 years, the average EBIT per Share Growth Rate was -43.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Chordia Therapeutics's EBIT per Share or its related term are showing as below:

TSE:190A' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -43   Med: -43   Max: -43
Current: -43

During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of Chordia Therapeutics was -43.00% per year. The lowest was -43.00% per year. And the median was -43.00% per year.

TSE:190A's 3-Year EBIT Growth Rate is ranked worse than
87.35% of 1249 companies
in the Biotechnology industry
Industry Median: 2.8 vs TSE:190A: -43.00

Chordia Therapeutics's EBIT for the six months ended in Aug. 2024 was 円-1,801.40 Mil.

Chordia Therapeutics EBIT per Share Historical Data

The historical data trend for Chordia Therapeutics's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics EBIT per Share Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24
EBIT per Share
-10.49 -27.91 3.76 -30.67

Chordia Therapeutics Semi-Annual Data
Aug21 Aug22 Aug23 Aug24
EBIT per Share -10.49 -27.91 3.76 -30.67

Chordia Therapeutics EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Chordia Therapeutics's EBIT per Share for the fiscal year that ended in Aug. 2024 is calculated as

EBIT per Share(A: Aug. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=-1801.395/58.729
=-30.67

Chordia Therapeutics's EBIT per Share for the quarter that ended in Aug. 2024 is calculated as

EBIT per Share(Q: Aug. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=-1801.395/58.729
=-30.67

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT per Share for the trailing twelve months (TTM) ended in Aug. 2024 was 円-30.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chordia Therapeutics  (TSE:190A) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Chordia Therapeutics EBIT per Share Related Terms

Thank you for viewing the detailed overview of Chordia Therapeutics's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordia Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » EBIT per Share
Comparable Companies
Traded in Other Exchanges
N/A
Address
2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Website
https://www.chordiatherapeutics.com
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines